(ALLO) allogene therapeutics up to 40% by projectsyndicatedetails see chart. get ready to buy soon. up to 40% upside in this swing trade setup. Longby ProjectSyndicatePublished 2252
ALLO Announces FDA Clearance of the IND for ALLO-501ALLO: Allogene Therapeutics, Inc. 2019-01-28 08:30:00 Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) TherapyLongby RocketTickersPublished 110
